Gerstner, E. R., Yip, S., Wang, D. L., Louis, D. N., Iafrate, A. J., & Batchelor, T. T. (2009). MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. American Academy of Neurology.
Citación estilo ChicagoGerstner, E R., S. Yip, D L. Wang, D N. Louis, A J. Iafrate, and T T. Batchelor. MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. American Academy of Neurology, 2009.
Cita MLAGerstner, E R., et al. MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. American Academy of Neurology, 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.